Funding Opportunities

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The NIH-funded Brain Vascular Malformation Consortium (BVMC, U54 NS065705) is soliciting proposals for a one-year pilot project proposal. Proposals should focus on the following rare diseases and/or related outcomes in cerebral cavernous malformation (CCM), Sturge Weber syndrome (SWS), or hereditary hemorrhagic telangiectasia (HHT).

Sponsor: Brain Vascular Malformation Consortium (BVMC)

Eligibility Criteria: Proposals will be reviewed by the BVMC Executive Steering Committee and selected for funding based on the following criteria: clinical research potential in rare diseases, potential to enhance clinical trial readiness for any of the three BVMC diseases; thematic relationship to the aims and scope of the BVMC; scientific quality of the proposal; leverage existing BVMC (and RDCRN) resources and infrastructure, especially patient registries/databases; feasibility in projected time frame; ability to support promising junior investigators; ability to seed new collaborations that might lead to novel research concepts or therapeutic approaches; and ability to seed new collaborations that might lead to new grant proposals.

Application Due Date: 2023-03-17

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: The NIH-funded Brain Vascular Malformation Consortium (BVMC, U54 NS065705) is soliciting applications to support clinical/translational investigators who focus on the study of rare neurovascular diseases, including: cerebral cavernous malformation (CCM), Sturge Weber syndrome (SWS), or hereditary hemorrhagic telangiectasia (HHT).

Sponsor: Brain Vascular Malformation Consortium (BVMC)

Eligibility Criteria: We are seeking to support advanced post-doctoral or clinical fellows, junior faculty, or established investigators who wish to develop or refocus their careers on clinical research in rare diseases. Under exceptional circumstances, we will consider applications from medical and graduate students proposing year-long projects. BVMC scholars should choose a mentor and research project aligned with one or more of the three BVMC Projects at cooperating institutions. There is wide breadth and depth of expertise spread across the BVMC that provides a rich research and mentoring environment.

Application Due Date: 2023-03-17

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To initiate and support collaborative research on osteogenesis imperfecta (OI).

Sponsor: Brittle Bone Disorders Consortium (BBD)

Eligibility Criteria: Both internal and external investigators are encouraged to propose and conduct pilot studies.

Application Due Date: 2024-01-01

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The Michael Geisman Fellowship Grant program awards funding to post-doctoral trainees who are currently working on projects with clear relevance to osteogenesis imperfecta (OI), or who have projects that will enable them to develop expertise in OI research.

Sponsor: Osteogenesis Imperfecta Foundation

Eligibility Criteria: Applicant must hold an MD, DDS, DO, or PhD, and be appointed at the level of a post-doctoral trainee, or equivalent, within an academic institution. Applicant should have completed their Ph.D. or clinical training within the past five (5) years.

Application Due Date: 2024-10-21

Term: One - Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]).

Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | ALS Association

Eligibility Criteria: Any individual with the requisite scientific training, irrespective of country of residence or origin. Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies.

Application Due Date: 2021-07-30

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: This award aims to support young investigators engaged in clinical research focused on ALS, ALS-FTD, PLS, PMA, and HSP.

Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | American Brain Foundation

Eligibility Criteria: Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 5 years prior to the beginning of this award (July 1, 2024). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.

Application Due Date: 2023-09-14

Term: Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The goal of this training award is to support the development of future researchers in pediatric antimicrobial stewardship by providing mentorship to complete a scholarly research project in a timely manner during clinical or research training. Applicants may propose a research study that focuses on any aspect of antimicrobial stewardship. The project should be able to be completed in one year. Projects spanning more than one year will be considered if a portion of the project that answers a specific research question can be completed within the year timeframe.

Sponsor: ediatric Infectious Diseases Society (PIDS) and Pediatric Committee on Antimicrobial Stewardship (PCAS)

Eligibility Criteria: Candidates must be enrolled in a training program, which can encompass any number of disciplines, such as medical residency or fellowship, pharmacy residency, or graduate education. Interested applicants from fields or programs not specified above are encouraged to contact PIDS to discuss eligibility at pids@idsociety.org. Applicants must join PIDS prior to application.

Application Due Date: 2024-06-21

Term: 1 Year

Opportunity Type: Education and Career Development Opportunities

Goal: The APA Collaborative Research Network Young Investigator Award (APA-CRN YIA) provides support to young investigators who propose a study to be implemented within at least one of the three APA research networks: BORN, CORNET, and PRIS.

Sponsor: Academic Pediatric Association

Eligibility Criteria: The principal investigator and his/or chosen mentor(s) of each submitted proposal must be members of the Academic Pediatric Association.

Application Due Date: 2024-10-01

Opportunity Type: Education and Career Development Opportunities

Goal: The APA YIA Funding Path supports projects in health services research, medical education, adolescent medicine, public health, epidemiology, emergency medicine, child maltreatment, hospital medicine, developmental/behavioral pediatrics, and other general pediatric clinical research domains. The YIA Program is particularly interested in proposals that address health equity.

Sponsor: Academic Pediatric Association

Eligibility Criteria: The young investigator and his/her/their chosen mentor(s) must be members of the Academic Pediatric Association.

Application Due Date: 2024-10-01

Term: Annual

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Projects to eliminate the disease burden associated with rare pediatric viral diseases focusing on congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal enterovirus (EV) and human parechovirus (HPeV) sepsis.

Sponsor: Congenital and Perinatal Infections Consortium (CPIC)

Eligibility Criteria: This program is primarily intended to support full-time faculty who are early-stage investigators (see NIH definition). Faculty with previous or active K-awards are eligible and are encouraged to apply. Past CPIC pilot applicants are also encouraged, but subsequent applications should be “new” submissions. Postdoctoral fellows are eligible if a faculty appointment will be made on or before September 1, 2024. If this is the case, the applicant must include a letter from their Department Chair confirming their status. Applications will also be accepted from established investigators with a previous history of funding with justification of eligibility. Established investigators are eligible if the proposed research represents a major shift from his/her scientific portfolio to date. By providing an Eligibility Statement within the Pre-Application, established PIs have the opportunity to comment on how the proposed aims represent a major shift in science.

Letter of Intent Due Date: 2024-04-15

Application Due Date: 2024-06-05

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: Program impacts the research career development of the next generation of rare diseases researchers focusing on congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal enterovirus (EV) and parechovirus (HPeV) sepsis.

Sponsor: Congenital and Perinatal Infections Consortium (CPIC)

Eligibility Criteria: Open to interested fellows and early-stage faculty.

Application Due Date: Applications accepted on a rolling basis.

Term: One - Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: The PIDS Foundation has created an International Medical Graduate (IMG) Early Career Development Award designed to provide bridge financial support to IMGs as they transition from fellow to faculty.

Sponsor: PIDS Foundation

Eligibility Criteria: Candidates must possess a MD, MD/PhD, DO or equivalent from a non-U.S. medical school. At the time of application, candidates may: be in the final year of a pediatric ID fellowship, have completed an ID fellowship, and are in the final year of a general pediatric residency program, be within the first 2 years of their first appointment in pediatric infectious diseases after training completion. Current fellows and residents should have a planned primary appointment (accepted job offer) in pediatric infectious diseases. Applicants must be a current PIDS member at the time of application.

Application Due Date: 2024-01-15

Term: 1 Year

Opportunity Type: Education and Career Development Opportunities

Goal: The National CMV Foundation is pleased to fund innovative research related to maternal or congenital cytomegalovirus (CMV) infections.

Sponsor: National CMV Foundation

Eligibility Criteria: Priority will be given to early career researchers including mentored pre- and post-doctoral trainees or junior faculty members who have not been a principal investigator (PI) on a National Institutes of Health (NIH) grant. Trainee applicants must provide a letter of support and a mentoring plan from the Mentor. Mid-career researchers may be considered if congenital CMV is a new area for their research. Applications will be accepted from researchers in the United States and Canada.

Application Due Date: 2024-07-31

Term: 12 or 24 months, non-renewable

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The award is intended to support translational and clinical research involving vaccine development and/or pathogenesis or host-pathogen interaction moves the field towards the development of new vaccines and therapeutics. Studies of new uses of existing vaccines (e.g., use in a special population) may also be considered; however, preference will be made for studies that advance new knowledge, new insights into vaccine and immunotherapeutic development, pathogenesis and host-pathogen interactions. Research proposals that focus principally on disease surveillance or vaccine attitudes/hesitancy are unlikely to be funded.

Sponsor: Pichichero Family Foundation

Eligibility Criteria: Pediatric infectious diseases physicians and scientists (MD and/or PhD) are encouraged to apply. All applicants must be members of PIDS. Established investigators should provide evidence for how the proposed work represents a new direction that is not currently or previously funded.

Application Due Date: Applications accepted on a rolling basis.

Term: 2 years

Opportunity Type: Education and Career Development Opportunities

Goal: The award is intended to support scholarship in pediatric infectious diseases broadly, including basic science, translational, clinical, epidemiology, and quality improvement research. Given the brevity of the summer research experience, focused studies or well-defined contributions to larger research projects will be most successful.

Sponsor: Sanofi Pasteur

Eligibility Criteria: Eligible research involving: basic science, translational, clinical, epidemiology, quality improvement

Application Due Date: 2024-03-25

Term: Summer

Opportunity Type: Education and Career Development Opportunities

Goal: RAPID Scholar Awards Home / Programs & Awards / Research Funding Programs / RAPID Scholar Awards RAPID’s Scholar Awards awards target applicants (junior faculty and fellows in their last year of fellowship) who identify as underrepresented in medicine (UIM), or disabled.

Sponsor: Academic Pediatric Association

Eligibility Criteria: If applying for the NIDDK pathway, confirm that both the principal investigator and his/her chosen mentor(s) are current members of the Academic Pediatric Association; if applying for the PIDS pathway, confirm that both the principal investigator and his/her chosen mentor(s) are current members of PIDS. Applicants must identify as underrepresented in medicine (UIM), or disabled, who are committed to a career in academic general pediatrics. Proposals are welcome from those who are: fellows in the last year of fellowship, faculty members no more than 5 years out from completion of all training (fellowship or post-doc). Previous RAPID Scholars and YIA recipients are not eligible to apply.

Application Due Date: 2024-11-01

Term: 1 Year

Opportunity Type: Education and Career Development Opportunities

Goal: The goal of these programs is to foster the academic career development of physicians in Pediatric Infectious Diseases. Applicants are encouraged to pursue opportunities to conduct cutting-edge clinical, translational, and basic science research in fields such as public health, epidemiology, antimicrobial stewardship, health disparities, infection control, outcomes research, pharmacokinetics, pathophysiology, molecular pathogenesis, vaccine development, and other fields relevant to Pediatric Infectious Diseases.

Sponsor: Stanley and Susan Plotkin and Sanofi Pasteur

Eligibility Criteria: Candidates must possess a MD, MD/PhD, DO or equivalent and be a first or secondyear fellow in a Pediatric Infectious Diseases program in North America at the time of application. During the fellowship award period, the applicant is expected to devote the majority of effort (approximately 75%) conducting the research project under the direct supervision of a mentor. The primary or co-mentor must be a current PIDS member.

Application Due Date: 2024-04-01

Term: Total costs per year for 2 years

Opportunity Type: Education and Career Development Opportunities

Goal: The goal of these programs is to foster the academic career development of physicians in Pediatric Infectious Diseases. Applicants are encouraged to pursue opportunities to conduct cutting-edge clinical, translational, and basic science research in fields such as public health, epidemiology, antimicrobial stewardship, health disparities, infection control, outcomes research, pharmacokinetics, pathophysiology, molecular pathogenesis, vaccine development, and other fields relevant to Pediatric Infectious Diseases.

Sponsor: Stanley and Susan Plotkin and Sanofi Pasteur

Eligibility Criteria: Candidates must possess an MD or an MD/PhD or equivalent and be a first-year fellow in an accredited pediatric infectious diseases fellowship training program in North America. During the fellowship award period (July 1, 2024-2-June 20, 2027), the applicant is expected to devote the majority of effort conducting the research project under the direct supervision of a mentor –approximately 75% during the first year of support, increasing to approximately 90% during the subsequent 2 years.

Application Due Date: 2024-04-01

Term: 3 years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To allow CEGIR investigators to initiate new projects relevant to eosinophilic esophagitis (EoE), eosinophilic gastritis (EoG), eosinophilic enteritis (EoN), and/or eosinophilic colitis (EoC).

Sponsor: Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Patient Advocacy Groups (American Partnership For Eosinophilic Disorders (APFED) | Campaign Urging Research for Eosinophilic Disease (CURED) | Eosinophilic Family Coalition (EFC) | The International Gastrointestinal Eosinophilic Researchers (TIGER) | National Institute of Allergy and Infectious Diseases (NIAID) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: MD, DO, PhD, or MD/PhD who is a member of CEGIR and full-time faculty at an academic institution in the USA or NIH

Application Due Date: Applications accepted on a rolling basis.

Term: One - Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: To train experts to investigate eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, physicians, patients, and professional organizations.

Sponsor: Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Patient Advocacy Groups (American Partnership For Eosinophilic Disorders (APFED) | Campaign Urging Research for Eosinophilic Disease (CURED) | Eosinophilic Family Coalition (EFC) | The International Gastrointestinal Eosinophilic Researchers (TIGER) | National Institute of Allergy and Infectious Diseases (NIAID) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: Applicants must be physicians trained in Internal Medicine, Pediatrics or Pathology with ongoing or completed subspecialty training (within 5 years of award start date) in a related field in an ACGME-accredited training program. Candidates should be US citizens, US permanent residents, or possess a valid visa to work in the US.

Application Due Date: Applications accepted on a rolling basis.

Term: Three Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The objective of the PFC is to serve as an engine and source of funding support for translational research across these three rare brain disorders to further our understanding of biological processes and development of novel therapies. The PFC aims to support collaboration across disciplines and take advantage of key infrastructure across the consortium to drive research that enhances not only clinical understanding but also bolsters community education and family engagement, in order to accelerate development of new therapies.

Sponsor: Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: Applications will be accepted from investigators interested in research on TSC, PHTS and PMS disorders or research across these and/or related disorders.

Application Due Date: 2023-04-15

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: To support development in characterizing the developmental alterations associated with PTEN variants.

Sponsor: Developmental Synaptopathies Consortium (DSC) | PTEN Research Foundation

Eligibility Criteria: This opportunity is open to all investigators eligible to work at any of the Developmental Synaptopathies Consortium PHTS sites: Boston Children’s Hospital, Cleveland Clinic, Cincinnati Children’s Hospital, Stanford University and University of California, Los Angeles. If not located at a DSC site as above: the applicant can either identify an investigator from one of the DSC sites with complementary research interests or propose an experimental plan to be matched with the appropriate mentor by the DSC. Applicant’s institution is where the proposed work will take place.

Application Due Date: 2021-07-02

Term: Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: To help characterize neuropsychiatric phenotypes in patients with Phelan-McDermid syndrome (PMS).

Sponsor: Phelan-McDermid Syndrome Foundation (PMSF) | Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: Highly qualified postdoctoral applicants with an MD, PhD, or MD/PhD, for the Phelan-McDermid Syndrome Foundation/Developmental Synaptopathies Consortium Young Investigator Fellowship. The ideal candidate has a clinical and/or research background in psychiatry, psychology, or neurology with a focus on neurodevelopmental disorders, and seeks to complement their expertise to become a leader in this growing field.

Application Due Date: 2022-01-14

Term: Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: The fellow will work within the NIH-funded Developmental Synaptopathies Consortium (DSC), a project within the Rare Disease Clinical Research Network (RDCRN), under the training of leaders in the field with a pre-established infrastructure for recruiting and phenotyping large numbers of patients with this rare disorder. Areas of potential research include, but are not limited to: iPSC derived neuronal modeling of TSC, characterization of the natural history of TSC, and development of endpoints for clinical trials in TSC.

Sponsor: TS Alliance | Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: MD, PhD, or MD/PhD applicants. The ideal candidate has a clinical or research background in either TSC biology or neurodevelopmental disorders and seeks to complement their expertise to become a leader in this growing field.

Application Due Date: 2022-03-15

Term: Two Years

Opportunity Type: Education and Career Development Opportunities

Goal: To facilitate career development for junior investigators interested in clinical and translational research relating to dystonia, or to provide a mechanism for more senior investigators from other fields to get involved in dystonia research.

Sponsor: Dystonia Medical Research Foundation | National Institute of Neurological Disorders and Stroke (NINDS) | Office of Rare Diseases Research (ORDR) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: Applications must focus on dystonia. Applicants who are not part of the Dystonia Coalition may also apply. US citizenship and affiliation with a US institution are not required.

Application Due Date: 2023-04-01

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To foster the most promising clinical and translational studies of direct relevance to dystonia.

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Office of Rare Diseases Research (ORDR) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: Applications must focus on clinical or translational projects with direct relevance to dystonia. The Dystonia Coalition is particularly interested in applicants focusing on projects that exploit data and/or resources already collected by the Dystonia Coalition and/or projects that encourage collaborations by involving different centers of the Dystonia Coalition, although independent projects related to dystonia are also welcome.

Application Due Date: 2023-04-01

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: Provides support for career development of biochemically trained professionals who have made a commitment to patient-oriented research in the Congenital Disorders of Glycosylation (CDG) and who have the potential to develop into productive preclinical investigators.

Sponsor: Frontiers in Congenital Disorders of Glycosylation (FCDGC)

Eligibility Criteria: Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of independent funding are encouraged.

Application Due Date: 2021-01-01

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The FCDGC provides funds for projects that will exclusively focus on CDG-related science and it is meant to produce preliminary data supporting areas of research that are either new in the CDG field or new to an established investigative team. We will especially focus on projects that have the potential for high impact on CDG patient care. The scope of projects supported by this P&F award mechanism will include any step of the CDG care continuum, ranging from novel concepts in clinical management, developing novel diagnostics, as well as exploring pathomechanisms and new therapeutics (human studies) in CDG. FCDGC will value proposals that are in the high risk, high impact category. The consortium also aims to form new multidisciplinary collaborations that will enhance the integration of the techniques offered at the participating institutions that will benefit multiple investigators.

Sponsor: Frontiers in Congenital Disorders of Glycosylation (FCDGC) | CDG Care

Eligibility Criteria: All basic, translational, or clinical investigators located at institutions within the United States who are eligible to apply as a Principal Investigator for NIH grants. Applications from investigators and/or institutions outside of the USA will be accepted and reviewed for funding by CDG CARE. Early-stage investigators and investigators who are new to the field of CDG are especially encouraged to apply. Investigators who have extensive research programs in CDGs are generally ineligible for funding (i.e. R01-style grants focused on CDG).

Application Due Date: 2023-01-03

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: The PCD Foundation Margaret W. Leigh Early Career Investigator Award supports emerging PhD and physician scientists who are actively involved in research in primary ciliary dyskinesia to allow them to develop into independent biomedical investigators. The proposed research must be relevant to the mission of the PCD Foundation, improving the health and well-being of patients with primary ciliary dyskinesia

Sponsor: Co-funded by ATS and PCD Foundation

Eligibility Criteria: Early-stage investigators and fellows

Application Due Date: 2024-12-16

Term: one year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: A mentored award designed to provide "protected time" for clinically trained individuals to receive supervised training in biomedical research related to leukodystrophies. A long-term goal is to establish a Leukodystrophy Center at each award recipient’s local institution. The award supports a period of supervised research, in conjunction with career development opportunities, for physician-scientists who require additional mentored training and support during development of an innovative research project.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible. There are also certain circumstances in which individuals with a PhD may be eligible, outlined below. Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of funding (i.e., “high-risk/high-yield”) are encouraged.

Application Due Date: 2023-02-20

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To generate preliminary research data needed to secure more substantial funding through traditional federal, institutional, and/or industry grant mechanisms. Recognizing the importance of creating a sustainable infrastructure for collaborative research and excellence in clinical care, the GLIA-CTN Pilot Project Award is designed to enhance clinical trial readiness in the leukodystrophies through clinical/translational research in biomarkers, or assays to assess therapeutics, or other initiatives directed towards clinical trial readiness.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible. There are also certain circumstances in which individuals with a PhD may be eligible. Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of funding (i.e., “high-risk/high-yield”) are encouraged.

Application Due Date: 2023-02-21

Term: One Year

Opportunity Type: Other

Goal: To develop a study team member’s skill as an emerging leader in addressing disparities, underrepresentation and improving outcomes among populations that are traditionally underserved in clinical research.

Sponsor: Inherited Neuropathy Consortium (INC)

Eligibility Criteria: This program is designed for junior study team members who are planning to attend a graduate program in a clinical or clinical research-related discipline.

Application Due Date: 2021-09-03

Opportunity Type: Education and Career Development Opportunities

Goal: The fellowships will offer a broad training in all aspects of clinical research in inherited neuropathies as well as an opportunity to conduct a more detailed research project of the trainee’s choice.

Sponsor: Inherited Neuropathy Consortium (INC)

Eligibility Criteria: Applicants will be expected to have completed a residency in neurology and preferably one year of a neuromuscular fellowship or equivalent. Under certain circumstances more senior applicants including those starting junior faculty positions will be considered. For applicants, an essential requirement will be the long term career aim to develop a clinical or laboratory research interest in hereditary neuropathies.

Term: One - Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Cure Sanfilippo Foundation seeks to support research that fills critical gaps in current knowledge across basic science, clinical care, and translational therapeutics which will ultimately improve the lives of children with Sanfilippo syndrome. Scientist-clinician-patient collaborations are highly encouraged and an area of active engagement for the Foundation

Sponsor: The Cure Sanfilippo Foundation

Eligibility Criteria: All funding awards are contingent upon alignment with the goals and priorities of the Foundation and availability of resources.

Letter of Intent Due Date: 2022-08-17

Application Due Date: 2022-08-29

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The Foundation’s aim in supporting trainees is to build a pipeline of talent among early career scientists and clinicians focused on Sanfilippo syndrome from within and outside of the field of lysosomal diseases.

Sponsor: The Cure Sanfilippo Foundation

Eligibility Criteria: All funding awards are contingent upon alignment with the goals and priorities of the Foundation and availability of resources.

Application Due Date: 2022-08-29

Term: Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Seeking applications addressing ML II/III, MPS I, MPS II, MPS III, MPS IVA, or MPS VI, alone or as part of a comparative approach involving other syndromes, as well as physiological systems with commonality between individual MPS and ML disorders.

Sponsor: National MPS Society

Eligibility Criteria: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to apply. A PI must be institutionally eligible to apply for, be awarded, and administer an extramural research grant.

Letter of Intent Due Date: 2022-03-15

Application Due Date: 2022-05-15

Term: One - Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Seeking applications addressing ML II/III, MPS I, MPS II, MPS III, MPS IVA, or MPS VI, alone or as part of a comparative approach involving other syndromes, as well as physiological systems with commonality between individual MPS and ML disorders.

Sponsor: National MPS Society

Eligibility Criteria: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to apply. A PI must be institutionally eligible to apply for, be awarded, and administer an extramural research grant.

Letter of Intent Due Date: 2022-03-15

Application Due Date: 2022-05-15

Term: One - Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Seeking applications addressing ML II/III, MPS I, MPS II, MPS III, MPS IVA, or MPS VI, alone or as part of a comparative approach involving other syndromes, as well as physiological systems with commonality between individual MPS and ML disorders.

Sponsor: National MPS Society

Eligibility Criteria: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to apply. A PI must be institutionally eligible to apply for, be awarded, and administer an extramural research grant.

Letter of Intent Due Date: 2022-03-15

Application Due Date: 2022-05-15

Term: One - Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: NTSAD’s Research Initiative Program is soliciting proposals for innovative research projects that involve basic research, translational studies or clinical studies in the following diseases: Tay-Sachs, Canavan, GM1, and Sandhoff diseases.

Sponsor: National Tay-Sachs & Allied Diseases Association (NTSAD)

Eligibility Criteria: Projects that focus on understanding the pathophysiology and the role of inflammation in TaySachs, Canavan, GM1, and Sandhoff diseases, or the process of myelination and how it is affected by disease are of particular interest. Applicants are strongly encouraged to submit proposals for clinical tools that support future trials across the severity spectrum of any given indication. This may include developing severity scales for disease staging, translational biomarkers with clinical utility, or measurable and clinically meaningful efficacy endpoints for clinical trials.

Letter of Intent Due Date: 2022-02-18

Application Due Date: 2022-04-01

Term: One - Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Cure Sanfilippo Foundation seeks to support research that fills critical gaps in current knowledge across basic science, clinical care, and translational therapeutics which will ultimately improve the lives of children with Sanfilippo syndrome.

Sponsor: The Cure Sanfilippo Foundation

Eligibility Criteria: All funding awards are contingent upon alignment with the goals and priorities of the Foundation and availability of resources.

Letter of Intent Due Date: 2022-08-17

Application Due Date: 2022-08-29

Term: Year 2 funding will be dependent upon progress dem

Opportunity Type: Education and Career Development Opportunities

Goal: The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.

Sponsor: Myasthenia Gravis Rare Disease Network (MGNet)

Eligibility Criteria: Applicants must have a MD (or equivalent) or PhD clinical fellows, post-doctoral fellows, or junior faculty are eligible. Applicants must identify a primary mentor with appropriate content expertise and experience mentoring young investigators. Candidates should be US citizens, US permanent residents, or non-US citizens with a valid visa to work in the US. MGNet Scholars do not have be at a MGNet site.

Application Due Date: 2024-10-01

Term: One year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Pilot studies must be designed to access the resources of MGNet and focused on clinical research, including fulfilling the definition of clinical research and exclusion of animal studies.

Sponsor: Myasthenia Gravis Rare Disease Network (MGNet) | Myasthenia Gravis Foundation of America | Conquer MG

Eligibility Criteria: The PI must hold an MD, PhD, MD/PhD, RN or more advanced, PharmD, DDS, DVM, or equivalent and be a faculty member at an academic institution.

Application Due Date: 2023-10-01

Term: Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To support investigator-initiated studies that employ NEPTUNE resources to advance clinical and translational research in glomerular disease.

Sponsor: NephCure Kidney International (NephCure)

Eligibility Criteria: NEPTUNE investigators and their collaborators OR scientists presently unaffiliated with NEPTUNE. Applicants are required to leverage the resources provided by NEPTUNE (infrastructure, accumulated human subjects and their associated data and materials) by bringing additional resources to conducting proposed investigations.

Letter of Intent Due Date: 2021-12-10

Application Due Date: 2022-03-29

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: To support advanced post-doctoral and junior faculty trainees, or established investigators interested in redirecting their investigative focus, who are preparing to become independent investigators in clinical and translational research in human glomerular disease.

Sponsor: Nephrotic Syndrome Study Network (NEPTUNE)

Eligibility Criteria: Clinical fellows (MD, MD/PhD, or equivalent degrees) who have completed their clinical training in nephrology or pathology or a subspecialty relevant to the study of glomerular disease in humans, advanced PhD post-doctoral fellows with training in biostatistics or translational research who seek advanced training in clinical research in human glomerular disease, junior faculty with training similar to that noted above, established investigators interested in refocusing their investigative path to include studies of glomerular disease in humans.

Application Due Date: 2022-02-03

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: We are soliciting applications for the North American Mitochondrial Disease Consortium (NAMDC) fellowship. This NIH funded 1 year fellowship will provide a unique clinical trials training opportunity for a senior fellow who will be trained to practice mitochondrial medicine.

Sponsor: National Institutes of Health

Eligibility Criteria: Clinicians, Senior Post-Doctoral Non-MD Scientists

Application Due Date: Applications accepted on a rolling basis.

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals as well as to close existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and currently hold a full-time position at any level (post-doctoral, research scientist, assistant/associate/full professor, etc.) at an established academic/research institution. Applicants will be considered from both the United States and internationally.

Application Due Date: 2022-05-01

Term: One Year with Potential of Renewal

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals as well as to close existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and currently hold a full-time position at any level (post-doctoral, research scientist, assistant/associate/full professor, etc.) at an established academic/research institution.

Application Due Date: 2022-05-01

Term: One Year with Potential of Renewal

Opportunity Type: Education and Career Development Opportunities

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals, promote and encourage young investigators into PKU-related research, to close the existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and have an opportunity to hold a full-time fellowship position at an established academic/research institution. Both United States and international academic institutions will be considered.

Application Due Date: 2022-05-01

Term: Two Years

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The objective of the PHEFREE pilot/feasibility program is to provide funding for studies of innovative ideas or hypotheses which, if successful, could lead to improvement in the understanding, prevention, diagnosis and/or treatment of hyperphenylalaninemia, biopterin defects and related conditions.

Sponsor: Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

Eligibility Criteria: MD, PhD, or MD/PhD investigators are eligible to apply.

Application Due Date: 2023-01-06

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: The primary mission of this program is to train and attract new investigators to research on hyperphenylalaninemia, biopterin defects and related conditions that is directly relevant to improvement in patient care, treatment and quality of life.

Sponsor: Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

Eligibility Criteria: Graduate and postgraduate trainees, postdoctoral fellows, and junior faculty within 10 years from the completion of their degree/residency/clinical training are eligible.

Application Due Date: 2023-01-06

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: For trainees, postdocs, and junior faculty who want to pursue new directions in porphyria research.

Sponsor: Porphyria Consortium (PC)

Eligibility Criteria: Priority will be given to junior investigators and postdocs. Established Investigators starting a new line of research in heme and porphyria may also apply.

Application Due Date: 2023-07-31

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To accelerate scientific work focused on improving the treatment, quality of life, and long-term outlook for patients with Hyper IgM. Special consideration will be given to well-defined projects focused on new approaches for curative treatment or significant improvement of existing treatments for Hyper IgM Syndrome aimed at reducing mortality and morbidity and improving quality of life.

Sponsor: Hyper IgM Foundation

Application Due Date: 2023-06-15

Opportunity Type: Other

Goal: To address the persistent challenge to achieve earlier diagnosis and expanding and diversifying our community.

Sponsor: Immune Deficiency Foundation (IDF)

Eligibility Criteria: All individuals, institutions, schools, and researchers.

Application Due Date: 2022-02-28

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To support well-defined research projects that have a specified benefit for improving the treatment, health, disease management, or diagnosis of people with primary immunodeficiencies (PI).

Sponsor: Immune Deficiency Foundation (IDF)

Eligibility Criteria: Eligibility is limited to those currently residing in the US. IDF is encouraging investigators that have an interest in pursuing a career in primary immunodeficiencies to apply.

Application Due Date: 2023-02-28

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Promote discovery in the field resulting in new peer-reviewed publications and to generate preliminary data necessary to fuel the design and implementation of clinical trials with robust mechanistic studies

Sponsor: Primary Immune Deficiency Treatment Consortium

Eligibility Criteria: Must have an appointment as an independent faculty member, eligible to apply for NIH grant funding, at an eligible PIDTC center. Junior faculty (within 5 years of their appointment) are encouraged to apply.

Letter of Intent Due Date: 2022-03-18

Application Due Date: 2022-05-02

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The purpose of the award is to encourage research in primary immunodeficiencies, particularly related to treatment by, transplantation, gene therapy, or best available medical management.

Sponsor: Primary Immune Deficiency Treatment Consortium (PIDTC)

Eligibility Criteria: Trainees or Junior Faculty with two years or less as a faculty member. Prior recipients can compete to receive one additional year of continuous funding with a progress report documenting that headway has been made on the research topic as long as they are still eligible by trainee status. Underrepresented minority applicants specifically encouraged to apply.

Application Due Date: 2022-04-25

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To improve long-term outcomes and/or reduce treatment related long-term complications, thereby improving quality of life post treatment and to find innovative approaches aimed at improving the diagnosis, the treatment, or maintaining the treatment continuity of Severe Combined Immune Deficiency (SCID) patients, within marginalized communities.

Sponsor: SCID Angels for Life Foundation

Eligibility Criteria: Eligible applicants should hold a Ph.D. or M.D degree. Applicants should be full-time permanent faculty members or post-doctoral fellows with a degree in fields related to SCID including, Immunology, Hematology, Cell Biology, Medicine, Biochemistry, Translational Research, or a similar field, at a research institute within the United States or Canada.

Application Due Date: 2021-12-15

Term: One Year

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To provide funding for pilot projects or feasibility projects that take maximum advantage of new clinical research opportunities in UCDs.

Sponsor: Urea Cycle Disorders Consortium (UCDC)

Eligibility Criteria: Anyone conducting UCD research is eligible. Must have a UCDC sponsor or we can help identify one, if needed. Only one application can be submitted from each UCDC site/institution.

Application Due Date: 2021-02-22

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: To train and attract new investigators who will conduct research in urea cycle disorders (UCDs) that contribute to a better understanding of UCDs and help improve the treatment and quality of life for individuals with UCDs.

Sponsor: Urea Cycle Disorders Consortium (UCDC)

Eligibility Criteria: Graduate and postgraduate trainees, postdoctoral fellows, and junior faculty within 10 years from the completion of their degree/residency/clinical training are eligible.

Application Due Date: 2023-04-17

Term: One Year

Opportunity Type: Education and Career Development Opportunities

Goal: For the Fellow to be involved in the care of enough patients with various forms of vasculitis to develop experience and expertise in the diagnosis and management of patients and to familiarize trainees with the major unmet research needs in vasculitis, the investigative techniques used in clinical and translational research in vasculitis, and understand how to conduct high-quality clinical research in vasculitis.

Sponsor: Various institutions

Eligibility Criteria: The candidate must be an MD (or equivalent) committed to a career in caring for patients with vasculitis, have a strong interest in conducting clinical investigation in vasculitis, have finished a residency and (preferably) have some sub-specialty training relevant to vasculitis (e.g., rheumatology, nephrology, or other disciplines), have a training license or full license to practice in the state/province where the Fellowship will take place from the START of the Fellowship period, be a citizen of the host country or have a valid visa that is acceptable to the host site from the START of the Fellowship/funding period. If specializing, VCRC Fellowship training will take place after the applicant has completed their subspecialty training.

Application Due Date: Applications accepted on a rolling basis.

Term: One - Two Years